Patents by Inventor Philippe Lenee

Philippe Lenee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6916787
    Abstract: A method for producing haemin proteins by (i) inserting into plant cells one or more nucleic acid molecules that each comprise at least one sequence coding for a protein component of an animal haemin protein capable of reversibly binding oxygen, or for a variant or portion of said protein component, and optionally a sequence coding for a selection agent; (ii) selecting cells containing nucleic acid coding for the protein component of the haemin protein; (iii) optionally propagating the transformed cells either in a culture or by regenerating whole transgenic or chimeric plants; and (iv) recovering and optionally purifying a haemin protein that includes a complex consisting of the protein or proteins coded for by said nucleic acid and at least one iron-containing porphyritic nucleus, or a plurality of such complexes.
    Type: Grant
    Filed: October 18, 2001
    Date of Patent: July 12, 2005
    Assignees: Institut National de la Sante et de Recherche Medicale, Meristern Therapeutics
    Inventors: Bertrand Merot, Wilfrid Dieryck, Philippe Lenee, Michael Marden, Veronique Gruber, Renee-Josee Pagnier, Sylvie Baudino, Claude Poyart
  • Publication number: 20040072317
    Abstract: The invention concerns the use of recombinant nucleotides sequences containing cDNA coding for a preduodenal lipase, or any sequence derived from this cDNA, for transforming plant cells in order to obtain recombinant preduodenal lipase or polypeptide derivatives.
    Type: Application
    Filed: September 17, 2002
    Publication date: April 15, 2004
    Applicant: Meristem Therapeutics
    Inventors: Philippe Lenee, Veronique Gruber, Sylvie Baudino, Bertrand Merot, Claude Benicourt, Claire Cudrey
  • Patent number: 6649812
    Abstract: Method of production of transgenic plants wholly transformed into To generation. The method consists of a) genetically transforming a meristem explant; b) selective culturing for the specific development, among all the transformed cells, of those cells giving rise to secondary meristems and/or those cells capable of resulting in neoformed foliar meristems, c) regenerating, from the cellular material obtained during step b), transgenic plants.
    Type: Grant
    Filed: March 25, 1999
    Date of Patent: November 18, 2003
    Assignee: Biogemma
    Inventors: Nathalie Knittel, Philippe Lenee
  • Patent number: 6646117
    Abstract: The invention relates to a nucleic acid sequence, called “polyribozyme”, which has an endoribonuclease activity and is capable of inactivating the gene for the capsid protein of a virus, characterized in that it comprises: i) a sequence complementary to at least a part of the gene or its transcript or to its replication intermediates and, includes at distinct sites in this complementary sequence: ii) a plurality of ribozyme catalytic regions; iii) and, optionally, one or more sequences non-complementary to the transcript of the said gene, the said non-complementary sequence(s) being inserted between two consecutive bases of the complementary sequence.
    Type: Grant
    Filed: November 2, 2000
    Date of Patent: November 11, 2003
    Assignee: Gene Shears. Pty. Limited
    Inventors: Philippe Lenee, Pascual Perez, Veronique Gruber, Gaelle Baudot, Catherine Ollivo
  • Patent number: 6573431
    Abstract: The invention concerns the use of recombinant nucleotides sequences containing cDNA coding for a preduodenal lipase, or any sequence derived from this cDNA, for transforming plant cells in order to obtain recombinant preduodenal lipase or polypeptide derivatives. The invention also concerns the use of genetically modified plants or parts thereof, or extracts of these plants or the use of recombinant preduodenal lipase or résultant polypeptide derivatives in the field of foodstuffs, or for producing medicaments, or in industry.
    Type: Grant
    Filed: July 2, 1999
    Date of Patent: June 3, 2003
    Assignees: Biochem S.A., Jouveinal S.A.
    Inventors: Philippe Lenee, VĂ©ronique Gruber, Sylvie Baudino, Bertrand Merot, Claude Benicourt, Claire Cudrey
  • Publication number: 20020194643
    Abstract: A method for producing haemin proteins by (i) inserting into plant cells one or more nucleic acid molecules that each comprise at least one sequence coding for a protein component of an animal haemin protein capable of reversibly binding oxygen, or for a variant or portion of said protein component, and optionally a sequence coding for a selection agent; (ii) selecting cells containing nucleic acid coding for the protein component of the haemin protein; (iii) optionally propagating the transformed cells either in a culture or by regenerating whole transgenic or chimeric plants; and (iv) recovering and optionally purifying a haemin protein that includes a complex consisting of the protein or proteins coded for by said nucleic acid and at least one iron-containing porphyritic nucleus, or a plurality of such complexes.
    Type: Application
    Filed: October 18, 2001
    Publication date: December 19, 2002
    Applicant: Meristern Therapeutics and Institut National de la Sante et de la Recherche Medicale
    Inventors: Bertrand Merot, Wilfrid Dieryck, Philippe Lenee, Michael Charles Marden, Veronique Gruber, Renee-Josee Pagnier, Sylvie Baudino, Claude Poyart
  • Patent number: 6344600
    Abstract: A method for producing human hemoglobin proteins by (i) inserting into plant cells one or more nucleic acid molecules that each comprise at least one sequence coding for a protein component of a human hemoglobin protein capable of reversibly binding oxygen, and optionally a sequence coding for a selection agent; (ii) selecting cells containing nucleic acid coding for the protein component of the human hemoglobin protein; (iii) optionally propagating the transformed cells either in a culture or by regenerating whole transgenic or chimeric plants; and (iv) recovering and optionally purifying the human hemoglobin protein that includes a complex consisting of the protein or proteins coded for by the nucleic acid and at least one iron-containing polphyritic nucleus, or a plurality of such complexes.
    Type: Grant
    Filed: June 9, 1998
    Date of Patent: February 5, 2002
    Assignees: Meristem Therapeutics, Institut National de la Sante et de la Recherche Medicale
    Inventors: Bertrand Merot, Wilfrid Dieryck, Philippe Lenee, Michael Marden, Veronique Gruber, Renee-Josee Pagnier, Sylvie Baudino, Claude Poyart
  • Patent number: 6265634
    Abstract: The invention relates to a nucleic acid sequence, called “polyribozyme”, which has an endoribonuclease activity and is capable of inactivating the gene for the capsid protein of a virus, characterized in that it comprises: i) a sequence complementary to at least a part of the gene or its transcript or to its replication intermediates and, includes at distinct sites in this complementary sequence: ii) a plurality of ribozyme catalytic regions; iii) and, optionally, one or more sequences non-complementary to the transcript of the said gene, the said non-complementary sequence(s) being inserted between two consecutive bases of the complementary sequence.
    Type: Grant
    Filed: October 25, 1995
    Date of Patent: July 24, 2001
    Assignee: Gene Shears Shears Pty. Ltd.
    Inventors: Philippe Lenee, Pascual Perez, Veronique Gruber, Gaelle Baudot, Catherine Ollivo